PDL BioPharma (PDLI) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Net income per basic share (in dollars per share): 0.08
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net income per basic share (in dollars per share): 0.08
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q3 EPS of $0.61, $0.05 better than the analyst estimate of $0.56. Revenue for the quarter came in at $164.6 million versus the consensus estimate of $165.1 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
